Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe.
This is a clinical trial investigating the effectiveness and the safety of using biphasic
insulin aspart 30 both for initiation and intensification of insulin treatment in type 2
diabetes.